The double face of IL-1β in lung cancer

Interleukin (IL)-1β is known to promote lung cancer growth in both humans and mice. However, in the context of the current standard of care, which includes chemotherapy and immune checkpoint inhibitors, IL-1β can overcome resistance.

Authors

Institutions

Publication Details

Journal
OncoImmunology
Published
2026-02-03
DOI
https://doi.org/10.1080/2162402x.2026.2622661
Primary Topic
Immune Response and Inflammation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The double face of IL-1β in lung cancer

Anaïs Perrichet, Cédric Rébé, François Ghiringhelli
OncoImmunology
Immune Response and Inflammation
article

The double face of IL-1β in lung cancer

Anaïs Perrichet, Cédric Rébé, François Ghiringhelli
article en

Abstract

Interleukin (IL)-1β is known to promote lung cancer growth in both humans and mice. However, in the context of the current standard of care, which includes chemotherapy and immune checkpoint inhibitors, IL-1β can overcome resistance.

OncoImmunologyVol. 15(1)
Centre Georges François Leclerc (FR)
Good health and well-being
Openalex Percentile: Top 68%
Immune Response and Inflammation
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The double face of IL-1β in lung cancer — Anaïs Perrichet, Cédric Rébé, et al. · OncoImmunology (2026) | TGRS Research Map | TGRS